Dupilumab成功治疗9岁男孩嗜酸性脓疱性毛囊炎。

IF 1.2 4区医学 Q3 DERMATOLOGY

Pediatric Dermatology Pub Date : 2025-09-01 Epub Date: 2025-03-06 DOI:10.1111/pde.15908

Xi Tan, Shu Nie, Bin Chen, Zhouwei Wu

{"title":"Dupilumab成功治疗9岁男孩嗜酸性脓疱性毛囊炎。","authors":"Xi Tan, Shu Nie, Bin Chen, Zhouwei Wu","doi":"10.1111/pde.15908","DOIUrl":null,"url":null,"abstract":"A 9-year-old boy with eosinophilic pustular folliculitis (EPF) was successfully treated with dupilumab. While reported in adult EPF, this is the first case of EPF treated with dupilumab in a child. Our case suggests dupilumab might be a favorable therapeutic option for EPF in children. Further research is needed to fully elucidate the efficacy and safety of dupilumab in children with EPF and to identify predictive factors for treatment response.","PeriodicalId":19819,"journal":{"name":"Pediatric Dermatology","volume":" ","pages":"1044-1046"},"PeriodicalIF":1.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Successful Treatment of Eosinophilic Pustular Folliculitis With Dupilumab in a 9-Year-Old Boy.\",\"authors\":\"Xi Tan, Shu Nie, Bin Chen, Zhouwei Wu\",\"doi\":\"10.1111/pde.15908\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 9-year-old boy with eosinophilic pustular folliculitis (EPF) was successfully treated with dupilumab. While reported in adult EPF, this is the first case of EPF treated with dupilumab in a child. Our case suggests dupilumab might be a favorable therapeutic option for EPF in children. Further research is needed to fully elucidate the efficacy and safety of dupilumab in children with EPF and to identify predictive factors for treatment response.\",\"PeriodicalId\":19819,\"journal\":{\"name\":\"Pediatric Dermatology\",\"volume\":\" \",\"pages\":\"1044-1046\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/pde.15908\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/pde.15908","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

一名患有嗜酸性粒细胞性脓疱性毛囊炎（EPF）的9岁男孩成功地接受了dupilumab治疗。虽然在成人EPF中有报道，但这是第一例儿童用dupilumab治疗EPF。我们的病例提示dupilumab可能是儿童EPF的一个有利的治疗选择。需要进一步的研究来充分阐明dupilumab在EPF患儿中的有效性和安全性，并确定治疗反应的预测因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Successful Treatment of Eosinophilic Pustular Folliculitis With Dupilumab in a 9-Year-Old Boy.

A 9-year-old boy with eosinophilic pustular folliculitis (EPF) was successfully treated with dupilumab. While reported in adult EPF, this is the first case of EPF treated with dupilumab in a child. Our case suggests dupilumab might be a favorable therapeutic option for EPF in children. Further research is needed to fully elucidate the efficacy and safety of dupilumab in children with EPF and to identify predictive factors for treatment response.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pediatric Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

6.70%

发文量

269

审稿时长

1 months

期刊介绍： Pediatric Dermatology answers the need for new ideas and strategies for today''s pediatrician or dermatologist. As a teaching vehicle, the Journal is still unsurpassed and it will continue to present the latest on topics such as hemangiomas, atopic dermatitis, rare and unusual presentations of childhood diseases, neonatal medicine, and therapeutic advances. As important progress is made in any area involving infants and children, Pediatric Dermatology is there to publish the findings.